Key facts
- It has raised $1.2M across 1 recorded rounds; the latest was Seed Round ($1.9M) in Jul 2025.
- Notable investors include SOSV, IndieBio, rpv.
- Deep Root Biolabs has filed 2 Form Ds with the SEC since 2025, most recently May 2026 ($1.9M sold to 11 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Deep Root Biolabs
Funding rounds
1 roundsAbout Deep Root Biolabs
Developer of a synthetic biology-based platform designed for environmental, agricultural, and resource optimization purposes. The company's platform integrates a bio-mining system with remediation services utilizing engineered biological processes, including proprietary tools that address challenges in food production, mineral recovery, and ecological restoration, enabling landowners, farmers, and sustainability-focused organizations to implement scalable, science-driven interventions for clean and resilient ecosystems.
- Sector
- Healthcare
- HQ
- Baltimore, MD, United States
- Founded
- 2025
- Employees
- 3
- Website
- deeprootbio.com/
- Ownership
- Privately Held (backing)
Deep Root Biolabs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Deep Root Biolabs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Deep Root Biolabs in its N-PORT filings yet. We sweep new filings monthly.